Development and validation of an instrument to measure collaborative goal setting in the care of patients with diabetes
Research Design and Methods: A random sample of 400 patients aged 40 years or older, receiving diabetes care from the Virginia Commonwealth University Health System between 8/2012 – 8/2013 were mailed a survey containing potential PM-CGS items (n=41) as well as measures of patient demographics, self-efficacy, trust in their physician, and self-management behaviors. Confirmatory factor analysis was used to evaluate instrument construct validity. External validity was evaluated via a structural equation model (SEM) that tested the association of the PM-CGS with self-management behaviors. The direct and two mediated (via trust and self efficacy) pathways were tested. .
Results: A total of 259 patients responded to the survey (64% response rate), of whom 192 were eligible for inclusion. Results from the factor analysis supported a 37-item measure of patient-perceived CGS spanning five domains: listen and learn; share ideas; caring relationship; measurable objective and goal achievement support (χ = 4366.13, p<.001; RMSEA = .08). Results from the SEM confirmed a relationship between the CGS measure and self-management (p<.001), which was partially mediated by self-efficacy (p<.05).
Conclusions: Collaborative goal setting can be validly measured by the 37-item PM-CGS. Use of the PM-CGS can help illustrate actionable deficits in goal setting discussions.
Learning Areas:Chronic disease management and prevention
Planning of health education strategies, interventions, and programs
Social and behavioral sciences
Describe and define a measure developed to evaluate collaborative goal setting.
Keyword(s): Diabetes, Patient-Centered Care
Qualified on the content I am responsible for because: I have been a principal investigator on an NIH funded project focused on defining collaborative goal setting, and developing a measure to assess this process.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.